FGFR1 and non-small cell lung carcinoma: Our study and a recent report [22] identify FGFR1 as a potential therapeutic target in NSCLC, where 8p11-12 amplification is common, suggesting that high levels of expression of FGFR1 may contribute to tumorigenesis or progression in NSCLC.